Identification of critical genetic variants associated with metabolic phenotypes of the Japanese population.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
11 11 2020
Historique:
received: 01 02 2020
accepted: 18 10 2020
entrez: 12 11 2020
pubmed: 13 11 2020
medline: 29 6 2021
Statut: epublish

Résumé

We performed a metabolome genome-wide association study for the Japanese population in the prospective cohort study of Tohoku Medical Megabank. By combining whole-genome sequencing and nontarget metabolome analyses, we identified a large number of novel associations between genetic variants and plasma metabolites. Of the identified metabolite-associated genes, approximately half have already been shown to be involved in various diseases. We identified metabolite-associated genes involved in the metabolism of xenobiotics, some of which are from intestinal microorganisms, indicating that the identified genetic variants also markedly influence the interaction between the host and symbiotic bacteria. We also identified five associations that appeared to be female-specific. A number of rare variants that influence metabolite levels were also found, and combinations of common and rare variants influenced the metabolite levels more profoundly. These results support our contention that metabolic phenotyping provides important insights into how genetic and environmental factors provoke human diseases.

Identifiants

pubmed: 33177615
doi: 10.1038/s42003-020-01383-5
pii: 10.1038/s42003-020-01383-5
pmc: PMC7659008
doi:

Substances chimiques

Multienzyme Complexes 0
uridine 5'-monophosphate synthase 74870-74-9
Orotate Phosphoribosyltransferase EC 2.4.2.10
Orotidine-5'-Phosphate Decarboxylase EC 4.1.1.23

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

662

Références

Tohoku J Exp Med. 2019;248(1):45-55
pubmed: 31130587
Hum Genet. 2013 Feb;132(2):189-99
pubmed: 23108985
Sci Rep. 2017 Aug 10;7(1):7829
pubmed: 28798341
Am J Pathol. 2018 May;188(5):1183-1194
pubmed: 29454749
J Biochem. 2019 Feb 1;165(2):139-158
pubmed: 30452759
Curr Opin Gastroenterol. 2015 Jan;31(1):69-75
pubmed: 25394236
Nat Rev Cancer. 2016 Oct;16(10):650-62
pubmed: 27634448
PLoS One. 2013;8(1):e51674
pubmed: 23382809
Nucleic Acids Res. 2018 Jan 4;46(D1):D551-D557
pubmed: 29069501
Nature. 2011 Aug 31;477(7362):54-60
pubmed: 21886157
Nat Commun. 2018 Aug 17;9(1):3294
pubmed: 30120222
Nat Commun. 2018 Jan 23;9(1):333
pubmed: 29362361
Prostaglandins Leukot Essent Fatty Acids. 2006 Mar;74(3):157-63
pubmed: 16410047
Biochem J. 2016 Jul 15;473(14):2011-22
pubmed: 27407170
Immunity. 2014 Aug 21;41(2):296-310
pubmed: 25065623
Nat Commun. 2015 Aug 21;6:8018
pubmed: 26292667
Nat Genet. 2017 Apr;49(4):568-578
pubmed: 28263315
Nat Genet. 2010 Oct;42(10):851-8
pubmed: 20818383
Nutrients. 2019 Jun 16;11(6):
pubmed: 31208147
Nat Genet. 2014 Jun;46(6):543-550
pubmed: 24816252
Adv Enzyme Regul. 1997;37:95-109
pubmed: 9381988
Pharmacogenomics J. 2013 Apr;13(2):148-58
pubmed: 22249354
J Epidemiol. 2016 Sep 5;26(9):493-511
pubmed: 27374138
BMC Med Genet. 2007 Sep 19;8 Suppl 1:S17
pubmed: 17903299
Curr Opin Lipidol. 2010 Feb;21(1):64-9
pubmed: 19809313
PLoS One. 2016 Aug 31;11(8):e0160555
pubmed: 27579980
J Epidemiol. 2021 Jan 5;31(1):65-76
pubmed: 31932529
Circulation. 2015 Mar 3;131(9):774-85
pubmed: 25573147
Nat Genet. 2009 Jan;41(1):56-65
pubmed: 19060906
Front Endocrinol (Lausanne). 2017 Oct 30;8:293
pubmed: 29163362
Am J Hum Genet. 1997 Mar;60(3):525-39
pubmed: 9042911
Nature. 2002 May 23;417(6887):447-52
pubmed: 12024214
Biochem Biophys Res Commun. 2012 Apr 20;420(4):901-6
pubmed: 22475485
Nat Protoc. 2007;2(11):2692-703
pubmed: 18007604
Adv Biosci Clin Med. 2018;6(1):1-5
pubmed: 29780691
Hum Mutat. 2017 Nov;38(11):1485-1490
pubmed: 28722276
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Mol Psychiatry. 2018 Mar;23(3):639-647
pubmed: 28115744
Expert Opin Drug Metab Toxicol. 2007 Apr;3(2):159-68
pubmed: 17428148
Gut. 2015 Jan;64(1):111-20
pubmed: 24647007
Hum Genome Var. 2019 Jun 18;6:28
pubmed: 31240104
Mol Genet Metab. 2008 Dec;95(4):195-200
pubmed: 18977676
FASEB J. 2010 Aug;24(8):2795-803
pubmed: 20305126
Cell Rep. 2018 Mar 27;22(13):3507-3520
pubmed: 29590619
Int J Epidemiol. 2013 Feb;42(1):76-85
pubmed: 22253318
PLoS Genet. 2008 Nov;4(11):e1000282
pubmed: 19043545
Hum Mol Genet. 2011 Oct 15;20(R2):R163-7
pubmed: 21880666
Nat Genet. 2012 Jan 29;44(3):269-76
pubmed: 22286219
Biochemistry. 2014 Apr 29;53(16):2732-8
pubmed: 24697329
Genes Cells. 2018 Jun;23(6):406-417
pubmed: 29701317
Sci Rep. 2016 Aug 16;6:31463
pubmed: 27528366
J Mol Biol. 2009 May 22;388(5):997-1008
pubmed: 19345228
Nat Genet. 2018 Oct;50(10):1412-1425
pubmed: 30224653
BMJ Open. 2015 Aug 28;5(8):e006772
pubmed: 26319774
J Exp Med. 2019 Jan 7;216(1):20-40
pubmed: 30322864
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Cell Metab. 2013 Jul 2;18(1):130-43
pubmed: 23823483
PLoS Genet. 2015 Jan 08;11(1):e1004835
pubmed: 25569235
PLoS Genet. 2014 Mar 13;10(3):e1004212
pubmed: 24625756
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Sci Rep. 2016 Nov 17;6:37375
pubmed: 27853278
Chem Res Toxicol. 2013 Aug 19;26(8):1139-55
pubmed: 23790050
Expert Opin Drug Metab Toxicol. 2013 Sep;9(9):1139-53
pubmed: 23650932
Expert Opin Drug Metab Toxicol. 2016 Oct;12(10):1169-79
pubmed: 27351777
Nat Commun. 2017 Nov 21;8(1):1632
pubmed: 29158497
J Pharmacol Exp Ther. 2009 Apr;329(1):262-71
pubmed: 19141711
Genes Brain Behav. 2013 Nov;12(8):792-801
pubmed: 24024963
Cell Host Microbe. 2017 Jul 12;22(1):25-37.e6
pubmed: 28704649

Auteurs

Seizo Koshiba (S)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan. koshiba@megabank.tohoku.ac.jp.
Graduate School of Medicine, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. koshiba@megabank.tohoku.ac.jp.
The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan. koshiba@megabank.tohoku.ac.jp.

Ikuko N Motoike (IN)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.
Graduate School of Information Sciences, Tohoku University, 6-3-09, Aramaki Aza-Aoba, Aoba-ku, Sendai, 980-8579, Japan.

Daisuke Saigusa (D)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.
Graduate School of Medicine, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.

Jin Inoue (J)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.
Graduate School of Medicine, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.

Yuichi Aoki (Y)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.
Graduate School of Information Sciences, Tohoku University, 6-3-09, Aramaki Aza-Aoba, Aoba-ku, Sendai, 980-8579, Japan.

Shu Tadaka (S)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.
Graduate School of Information Sciences, Tohoku University, 6-3-09, Aramaki Aza-Aoba, Aoba-ku, Sendai, 980-8579, Japan.

Matsuyuki Shirota (M)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.
Graduate School of Medicine, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.

Fumiki Katsuoka (F)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.
Graduate School of Medicine, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.

Gen Tamiya (G)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.
Graduate School of Medicine, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.

Naoko Minegishi (N)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.
Graduate School of Medicine, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.

Nobuo Fuse (N)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.
Graduate School of Medicine, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.

Kengo Kinoshita (K)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.
The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan.
Graduate School of Information Sciences, Tohoku University, 6-3-09, Aramaki Aza-Aoba, Aoba-ku, Sendai, 980-8579, Japan.

Masayuki Yamamoto (M)

Tohoku Medical Megabank Organization, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan. masiyamamoto@med.tohoku.ac.jp.
Graduate School of Medicine, Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. masiyamamoto@med.tohoku.ac.jp.
The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, 2-1, Seiryo-machi, Aoba-ku, Sendai, 980-8573, Japan. masiyamamoto@med.tohoku.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH